fig4
Figure 4. Occurrence and risk of LRAEs in AP-WD and NAP-WD patients. (A) Distribution of patients in the AP-WD and NAP-WD groups according to the presence or absence of LRAEs; (B) Kaplan-Meier curves showing the cumulative risk of LRAEs in the AP-WD and NAP-WD groups. Generated using GraphPad Prism 10 and R 4.3.0. LRAEs: Liver-related adverse events; NAP-WD: Wilson’s disease without autoimmune phenomena; AP-WD: Wilson’s disease with autoimmune phenomena.
